The U.S. Food and Drug Administration (FDA) has approved Guardant360 CDx as a companion diagnostic to identify patients with ...

NORTH DAKOTA (KXNET) — Yogurt isn’t just part of a great breakfast; it could have protective benefits against a certain type of aggressive colon cancer. Researchers at Mass General Brigham analyzed ...

Oxford Drug Design has announced new in vivo results that further validate its emerging first‑in‑class oncology programme, ...

This transcript has been edited for clarity. Hello. I'm David Kerr, professor of cancer medicine from University of Oxford. I'd like to talk today about a very nice study just published in The Lancet ...

Doctors are observing a concerning rise in colon cancer among individuals under 50, potentially linked to ultra-processed ...